GLAXO2024-10-012024-12-31 GLAXO2024-10-012024-12-31 GLAXO2024-10-012024-12-31in-bse-fin:OneOperatingExpenses01Member GLAXO2024-10-012024-12-31in-bse-fin:FourOperatingExpenses01Member GLAXO2024-12-31 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 500660 GLAXO NOTLISTED GlaxoSmithKline Pharmaceuticals Limited Equity 2024-04-01 2025-03-31 2025-02-14 2025-01-20 INR Lakhs Third quarter 13:30:00 15:00:00 2025-02-14 2025-02-14 Not applicable Single segment Pharmaceuticals 2024-10-01 2024-12-31 Unaudited Consolidated 9494200000.00 350700000.00 9844900000.00 974800000.00 1642300000.00 974500000.00 1247400000.00 900000.00 188000000.00 1736000000.00 6763900000.00 3081000000.00 0.00 3081000000.00 734900000.00 47300000.00 782200000.00 0.00 2298800000.00 0.00 0.00 0.00 0.00 2298800000.00 11800000.00 2310600000.00 0.00 0.00 1694100000.00 10 13.57 13.57 0.00 0.00 13.57 13.57 Debt equity, Debt service coverage ratio and interest service coverage ratio not calculated for the quarter and nine months ended 31st Dec 2024. Single segment 2024-04-01 2024-12-31 Unaudited Consolidated 27748400000.00 1052500000.00 28800900000.00 3846700000.00 5537100000.00 1005400000.00 4267300000.00 7300000.00 520700000.00 4650200000.00 19834700000.00 8966200000.00 46900000.00 9013100000.00 2358100000.00 7900000.00 2366000000.00 0.00 6647100000.00 0.00 0.00 0.00 0.00 6647100000.00 11800000.00 6658900000.00 0.00 0.00 1694100000.00 10 39.00 39.24 0.00 0.00 39.00 39.24 Other Expenses 1736000000.00 Other Expenses 4650200000.00 15700000.00 15700000.00 3900000.00 3900000.00